Altiva Equity Ex-Top 100 LS and WSIF Equity Ex-Top 100 compared on official AMFI NAVs — returns across six windows, a rebased NAV chart, expense ratio, AUM, risk band and portfolio overlap, refreshed daily.
Loading official AMFI data…Altiva Equity Ex-Top 100 LS and WSIF Equity Ex-Top 100 are both equity ex-top 100 ls Specialized Investment Funds, but from different houses — Edelweiss runs Altiva Equity Ex-Top 100 LS and The Wealth Company runs WSIF Equity Ex-Top 100. WSIF Equity Ex-Top 100 was the earlier of the two, launching in May 2026; Altiva Equity Ex-Top 100 LS followed in June 2026. Equity Ex-Top 100 Long-Short SIFs focus on companies outside the 100 largest by market capitalisation — the mid- and small-cap universe — with a long-short overlay.
Both sit inside SEBI's ₹10 lakh SIF category (₹1 lakh for accredited investors) and are compared below on live official AMFI NAVs — six return windows, a rebased NAV chart, expense ratio, AUM, risk band and what they hold, refreshed every trading day.
Factual highlights from the sourced figures below — informational only, not a recommendation.
| Metric | Altiva Equity Ex-Top 100 LS Edelweiss | WSIF Equity Ex-Top 100 The Wealth Company |
|---|---|---|
| Latest NAV | ₹10.3774 6 Nov 2026 | ₹10.3834 6 Nov 2026 |
| 1 day | ▼ 0.45% | ▼ 0.26% |
| 1 week | ▲ 4.95% | ▲ 5.84% |
| 1 month | ▼ 2.59% | ▲ 0.19% |
| 3 months | ▼ 5.95% | ▼ 3.91% |
| 6 months | — | — |
| Since inception | ▲ 3.77% | ▲ 3.83% |
| AUM | ₹1,535 Cr | ₹76 Cr |
| Expense ratio — base (Regular) | 1.79% | 2.10% |
| Expense ratio — total, all-in (Regular) | 3.02% | 3.98% |
| Risk band (AMC-declared) | 5 / 5 | 5 / 5 |
| Allotted | 8 Jun 2026 | 6 May 2026 |
| Strategy | Equity Ex-Top 100 LS | Equity Ex-Top 100 LS |
| Official AMFI NAVs as of 6 Nov 2026, Regular plan · Growth. Returns are absolute point-to-point changes, not annualised, and most SIFs are less than a year old — check each fund’s age before comparing. Past performance may or may not be sustained in future. Any highlight marks the higher or lower figure on that row; it is arithmetic, not a rating or a recommendation. Missing values show as “—”, never estimated. This table refreshes in your browser with the latest official figures. | ||
Real portfolio overlap, computed from each fund’s disclosed monthly holdings — long positions only.
| Shared holding | Sector | Altiva Equity Ex-Top 100 LSweight | WSIF Equity Ex-Top 100weight |
|---|---|---|---|
| HDFC Bank | Banks | 2.10% | 5.04% |
| Eris Lifesciences | Pharmaceuticals & Biotechnology | 1.91% | 0.94% |
Overlap = the sum of the lower of the two weights in each shared holding. Computed from the funds’ monthly portfolio disclosures — Altiva Equity Ex-Top 100 LS as of 30 Sep 2026, WSIF Equity Ex-Top 100 as of 30 Sep 2026. Long positions only; short and derivative exposures are excluded. Informational only, not a recommendation.
Our team distributes every live SIF and can explain how each strategy works, the liquidity terms and the paperwork. Education first — no pressure.